Moneycontrol
HomeNewsBusinessMarketsBritain borrows at negative interest rate for first time

Britain borrows at negative interest rate for first time

It joins Japan, Germany and some other European countries in selling debt yielding less than 0 percent, reflecting the prospect the coronavirus pandemic will cause a severe global recession and bond-buying by central banks to mitigate its impact.

May 20, 2020 / 19:39 IST
Story continues below Advertisement
Another investor backing as many as 7 Indian companies is UK-based Steadview Capital. Dream11, Nykaa and Lenskart are among some of its investees. (Image: Reuters)

Britain sold a government bond with a negative yield for the first time on Wednesday, meaning the government is effectively being rewarded for borrowing after investors agreed to be repaid slightly less than they lent.

It joins Japan, Germany and some other European countries in selling debt yielding less than 0 percent, reflecting the prospect the coronavirus pandemic will cause a severe global recession and bond-buying by central banks to mitigate its impact.

Story continues below Advertisement

Wednesday's auction saw 3.75 billion pounds ($4.6 billion) of gilts maturing in July 2023 sold at an average yield of -0.003 percent.

While investors will receive annual interest of 0.75 percent, they paid above face value for the bond so the cash return will be less than they have lent if they hold the debt to maturity.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show